Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Sang Yu

Showing results (221-230 of 349) with videos related to

Pageof 35
Sort By:
Clinical Pharmacology and Therapeutics|June 18, 2005
Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteersJae-Yong Chung, Joo-Youn Cho, Kyung-Sang Yu, et al.
Clinical Therapeutics|February 23, 2010
Pharmacodynamic (hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studiesBo-Hyung Kim, Jung-Ryul Kim, Min-Gul Kim, et al.
International Clinical Psychopharmacology|March 8, 2016
A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteersAnhye Kim, Kyoung Soo Lim, Howard Lee, et al.
Current Medical Research and Opinion|April 6, 2013
The effect of udenafil on the hemodynamics of healthy male volunteers administered tamsulosinMin-Gul Kim, Jung-Ryul Kim, Bo-Hyung Kim, et al.
Journal of Clinical Pharmacology|August 18, 2017
Safety, Tolerability, and Pharmacokinetic Characteristics of a Novel Nonopioid Analgesic, VVZ-149 Injections in Healthy Volunteers: A First-in-Class, First-in-Human StudyJaeseong Oh, SeungHwan Lee, Anhye Kim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 26, 2014
Effects of proton pump inhibitors on metformin pharmacokinetics and pharmacodynamicsAnHye Kim, Inbum Chung, Seo Hyun Yoon, et al.
Drug Design, Development and Therapy|July 17, 2014
Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting stateKyungho Jang, Seonghae Yoon, Sung-Eun Kim, et al.
Clinical Therapeutics|September 5, 2012
Evaluation of the pharmacokinetics, food effect, pharmacodynamics, and tolerability of DA-1229, a dipeptidyl peptidase IV inhibitor, in healthy volunteers: first-in-human studyTae-Eun Kim, Kyoung Soo Lim, Min Kyu Park, et al.
Pharmacogenetics and Genomics|November 9, 2020
A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylatorsHyounggyoon Yoo, Sang Chun Ji, Joo-Youn Cho, et al.
British Journal of Clinical Pharmacology|November 24, 2022
Pharmacokinetic and pharmacodynamic interaction between DWP16001, an sodium-glucose cotransporter 2 inhibitor and metformin in healthy subjectsByungwook Kim, Ki Young Huh, Jun Gi Hwang, et al.
Pageof 35

Showing results (221-230 of 349) with videos related to

Sort By:
Pageof 35
Clinical Pharmacology and Therapeutics|June 18, 2005
Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteersJae-Yong Chung, Joo-Youn Cho, Kyung-Sang Yu, et al.
Clinical Therapeutics|February 23, 2010
Pharmacodynamic (hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studiesBo-Hyung Kim, Jung-Ryul Kim, Min-Gul Kim, et al.
International Clinical Psychopharmacology|March 8, 2016
A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteersAnhye Kim, Kyoung Soo Lim, Howard Lee, et al.
Current Medical Research and Opinion|April 6, 2013
The effect of udenafil on the hemodynamics of healthy male volunteers administered tamsulosinMin-Gul Kim, Jung-Ryul Kim, Bo-Hyung Kim, et al.
Journal of Clinical Pharmacology|August 18, 2017
Safety, Tolerability, and Pharmacokinetic Characteristics of a Novel Nonopioid Analgesic, VVZ-149 Injections in Healthy Volunteers: A First-in-Class, First-in-Human StudyJaeseong Oh, SeungHwan Lee, Anhye Kim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 26, 2014
Effects of proton pump inhibitors on metformin pharmacokinetics and pharmacodynamicsAnHye Kim, Inbum Chung, Seo Hyun Yoon, et al.
Drug Design, Development and Therapy|July 17, 2014
Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting stateKyungho Jang, Seonghae Yoon, Sung-Eun Kim, et al.
Clinical Therapeutics|September 5, 2012
Evaluation of the pharmacokinetics, food effect, pharmacodynamics, and tolerability of DA-1229, a dipeptidyl peptidase IV inhibitor, in healthy volunteers: first-in-human studyTae-Eun Kim, Kyoung Soo Lim, Min Kyu Park, et al.
Pharmacogenetics and Genomics|November 9, 2020
A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylatorsHyounggyoon Yoo, Sang Chun Ji, Joo-Youn Cho, et al.
British Journal of Clinical Pharmacology|November 24, 2022
Pharmacokinetic and pharmacodynamic interaction between DWP16001, an sodium-glucose cotransporter 2 inhibitor and metformin in healthy subjectsByungwook Kim, Ki Young Huh, Jun Gi Hwang, et al.
Pageof 35